Showing results (221-230 of 351) with videos related to
Sort By:
Pageof 36
Journal of Medical Virology|February 11, 2018
Amino acid substitutions in the hepatitis C virus core region predict hepatocarcinogenesis following eradication of HCV RNA by all-oral direct-acting antiviral regimensFumihiro Ogata, Norio Akuta, Masahiro Kobayashi, et al.Intervirology|September 5, 2009
Association of amino acid substitution pattern in core protein of hepatitis C virus genotype 2a high viral load and virological response to interferon-ribavirin combination therapyNorio Akuta, Fumitaka Suzuki, Miharu Hirakawa, et al.Internal Medicine (Tokyo, Japan)|March 3, 2009
Combination therapy of peginterferon and ribavirin for chronic hepatitis C patients with genotype 1b and low-virus loadYasuji Arase, Fumitaka Suzuki, Norio Akuta, et al.Journal of Medical Virology|January 20, 2009
A matched case-controlled study of 48 and 72 weeks of peginterferon plus ribavirin combination therapy in patients infected with HCV genotype 1b in Japan: amino acid substitutions in HCV core region as predictor of sustained virological responseNorio Akuta, Fumitaka Suzuki, Miharu Hirakawa, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|January 11, 2013
Antitumor efficacy of transcatheter arterial chemoembolization with warmed miriplatin in hepatocellular carcinomaYuya Seko, Kenji Ikeda, Yusuke Kawamura, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|September 21, 2010
Administration of interferon for two or more years decreases early stage hepatocellular carcinoma recurrence rate after radical ablation: A retrospective study of hepatitis C virus-related liver cancerKenji Ikeda, Masahiro Kobayashi, Yuya Seko, et al.Liver International : Official Journal of the International Association for the Study of the Liver|April 5, 2011
Stage progression of small hepatocellular carcinoma after radical therapy: comparisons of radiofrequency ablation and surgery using the Markov modelKenji Ikeda, Masahiro Kobayashi, Yusuke Kawamura, et al.Intervirology|April 7, 2005
Virological and biochemical relapse after discontinuation of lamivudine monotherapy for chronic hepatitis B in Japan: comparison with breakthrough hepatitis during long-term treatmentNorio Akuta, Fumitaka Suzuki, Mariko Kobayashi, et al.Intervirology|March 4, 2010
Extending combination therapy with peginterferon plus ribavirin for genotype 2 chronic hepatitis C virological responders: a pilot study of 7 casesNorio Akuta, Fumitaka Suzuki, Yasuji Arase, et al.Journal of Gastroenterology and Hepatology|February 20, 2009
Efficacy of entecavir treatment for lamivudine-resistant hepatitis B over 3 years: histological improvement or entecavir resistance?Yoshiyuki Suzuki, Fumitaka Suzuki, Yusuke Kawamura, et al.Pageof 36